In this event, representatives from Johnson & Johnson Innovation will provide an overview of goals and missions, highlighting how Johnson & Johnson Innovation interacts with the entrepreneurial community through JLABS, JJDC, The Innovation Centers and Janssen Business & Development.
Following the presentation, the Johnson & Johnson Innovation team will meet one-on-one with early-stage companies and researchers interested in presenting their technology/solutions and discussing collaboration opportunities.
Companies/researchers interested in participating in the meeting need to apply before 9 February by submitting this form with non-confidential information in this link.
Johnson & Johnson Innovation is comprised of a family of complementary teams that bring meaningful solutions and flexible approaches to support collaboration. Our network brings expertise across all sectors: consumer, medical devices, pharmaceuticals and global public health. Companies can access our support via our Innovation Centers, JLABS, JJDC or our Business Development teams (read more about the Johnson & Johnson innovation network in this link)
Areas of Interest

One-on-one meetings with selected companies/researchers
*Attendees interested in participating in the one-on-one meetings need to apply before 9 February by submitting their non-confidential information in this link.
Senior Director, External Innovation Lead, World Without Disease Accelerator / Lung Cancer Initiative
Kai Stoeber is Senior Director, External Innovation at Johnson & Johnson Innovation. In his role he identifies and evaluates external opportunities, in partnership with the J&J Global External Innovation network, to accelerate the development of an innovative portfolio of projects, assets and solutions in support of disease prevention, interception and cure.